#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    HER2 mutant non-small cell lung cancer Leiomyosarcoma Short stature homeobox gene mutation Fabry's disease Neuronal ceroid lipofuscinosis Blastic plasmacytoid dendritic cell neoplasia Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Angiosarcoma NTRK gene fusion overexpression Univentricular heart Hereditary angioedema with C1 esterase inhibitor deficiency Bile acid synthesis disorder Neonatal asphyxia Ehlers-Danlos syndrome Isodicentric chromosome 15 syndrome More trials…

    Learn about Rare Diseases

    Angiosarcoma recurrent Haemophilia A with anti factor VIII – Basic Information Erdheim-Chester disease – Diagnostics Pemphigus – Life with Disease Factor VIII deficiency – Diagnostics Prolymphocytic leukaemia Richter’s syndrome Osteosarcoma recurrent – Diagnostics Ehlers-Danlos syndrome Pleomorphic leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fenoterol Hydrobromide Gad20-209-Fsp-A3 Tamibarotene ICOTROKINRA ULVIPRUBART HRS 9531 Lonapegsomatropin TROFOLASTAT HUMAN THROMBIN Ads-013 Trifluridine Vinblastine Sulfate Elacestrant Octocog Alfa Ephedrine Hydrochloride Anhydrous Glucose Bp Fluticasone Propionate Paclitaxel Patiromer Sacituzumab Govitecan More therapies…

    Learn about Your Condition

    Netherton's syndrome Psoriasis Arterial stiffness Rheumatoid arthritis HER2 protein overexpression Mast cell activation syndrome Metastases to meninges Piriformis syndrome Short stature Fibromyalgia Bronchiolitis Metastases to peritoneum Malignant glioma Alveolar proteinosis Pleomorphic leiomyosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z…

Twoja Przychodnia Poznańskie Centrum Medyczne Sp. z o.o.

ul. Marcelińska 92, Poznan, 60-324, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Phase 2 Randomized Double‑Blind Placebo‑Controlled Study of MH002 in Adults with Mild‑to‑Moderate Ulcerative Colitis Inadequately Controlled by 5‑ASA

    Recruiting

    2 1
    Czechia Italy Poland

  • Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Sodium Chloride
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study of mirikizumab and tirzepatide for adults with moderate to severe Crohn’s disease who are overweight or obese

    Recruiting

    3 1
    Investigated Drugs:
    • Tirzepatide
    • Mirikizumab
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    Croatia Czechia France Greece Hungary Italy +5

  • A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Austria Belgium Bulgaria Croatia Czechia Denmark +16

  • Study of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease

    Recruiting

    2 1 1
    Investigated Diseases:
    • Colitis
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Mirikizumab
    Belgium Germany Hungary Italy Poland

  • Phase 2 Randomized Study of Povetacicept to Assess Safety and Effectiveness in Adults with Generalized Myasthenia Gravis

    Recruiting

    2 1
    Investigated Drugs:
    • Povetacicept
    Poland

  • Orelabrutinib in Patients with Primary Progressive Multiple Sclerosis

    Recruiting

    3 1
    Investigated Diseases:
    • Primary progressive multiple sclerosis
    Austria Belgium Bulgaria Croatia Czechia Denmark +14

  • Nipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus

    Recruiting

    3 1
    Investigated Drugs:
    • Nipocalimab
    Bulgaria Czechia Denmark Finland France Germany +9

  • Long-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Zasocitinib
    Belgium Bulgaria Croatia Czechia Estonia France +7
1 2 3 … 7
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!